VAERS Explorer
Back to explore

Report #2826348

Received Feb 14, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (JANSSEN))JANSSENUNK——

Symptoms (1)

Guillain-Barre syndrome

Symptom narrative

Guillain-Barre syndrome; This spontaneous report received from a patient concerned a male patient of unspecified age. Received via J and J managed social media. The patient's height and weight were not reported. Age at time of vaccination was unknown. No past medical history, concurrent conditions or pre-existing medical conditions were reported. The patient received janssen covid-19 vaccine (suspension for injection, intramuscular, batch number not reported) dose, frequency and therapy dates not reported, additional dosage information included: dose series 1, for covid-19 prophylaxis. The batch number was not reported. The company is unable to perform follow up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced guillain-barre syndrome. (dose series 1) Now the patient have very weak muscles and now paralyzed. The action taken with janssen covid-19 vaccine was not applicable. The outcome of guillain-barre syndrome was not reported. This report was serious (other medically important condition).; Sender's Comments: V0: janssen covid-19 vaccine -Guillain-Barre syndrome. This event(s) is labeled per RA and is therefore considered potentially related.